Confo Therapeutics and DyNAbind Announce Drug Discovery Collaboration to Identify Novel GPCR-Modulating Compounds Read more
Roche announces positive results for first global phase III study investigating one-dose Xofluza (baloxavir marboxil) in children with flu Read more
GSK announces phase III start for its anti GM-CSF antibody, otilimab, in patients with rheumatoid arthritis (RA) Read more
Appili Signs $3M USD Grant Contract with the United States Department of Defense to Develop Antibiotics that Target Superbugs Read more
Incyte and Zai Lab Announce Collaboration and License Agreement for INCMGA0012 in Greater China Read more